Janssen announces submission of two applications to US FDA seeking approval of SIMPONI ARIA to treat polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis

Johnson & Johnson headquarters in New Brunswick, New Jersey. (Credit: Nikopoley)